Skip to main content

Advertisement

Peer Review reports

From: The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis

Original Submission
25 Jan 2006 Submitted Original manuscript
3 Feb 2006 Author responded Author comments - Russell Taichman
Resubmission - Version 2
3 Feb 2006 Submitted Manuscript version 2
15 Feb 2006 Reviewed Reviewer Report - Eva Corey
6 Mar 2006 Reviewed Reviewer Report - Suzanne Watt
1 Apr 2006 Author responded Author comments - Russell Taichman
Resubmission - Version 3
1 Apr 2006 Submitted Manuscript version 3
11 Apr 2006 Reviewed Reviewer Report - Eva Corey
19 May 2006 Reviewed Reviewer Report - Suzanne Watt
14 Jun 2006 Author responded Author comments - Russell Taichman
Resubmission - Version 4
14 Jun 2006 Submitted Manuscript version 4
3 Jul 2006 Reviewed Reviewer Report - Suzanne Watt
6 Jul 2006 Author responded Author comments - Russell Taichman
Resubmission - Version 5
6 Jul 2006 Submitted Manuscript version 5
17 Jul 2006 Author responded Author comments - Russell Taichman
Resubmission - Version 6
17 Jul 2006 Submitted Manuscript version 6
18 Jul 2006 Author responded Author comments - Russell Taichman
Resubmission - Version 7
18 Jul 2006 Submitted Manuscript version 7
Publishing
21 Jul 2006 Editorially accepted
21 Jul 2006 Article published 10.1186/1471-2407-6-195

You can find further information about peer review here.

Back to article page